1888PressRelease.com

Cd-biosciences.com - Cd Biosciences Company News Section

Cd Biosciences Press Release -

Cd-biosciences.com

CD BioSciences Introduces High Content Imaging Technology to Accelerate Drug Discovery Research
CD BioSciences has recently announced the launch of High Content Imaging technology to accelerate the drug discovery research.
November 29, 2022

CD BioSciences Introduces New Cell Death Solutions for Scientists
CD BioSciences recently launched a comprehensive panel of research solutions covering all aspects of study for cell death, particularly alkaliptosis.
November 26, 2022

CD BioSciences Launches Cell Death Solutions for Life Science Researchers
CD BioSciences recently announced the launch of a comprehensive panel of research solutions covering all aspects of cell death study.
October 22, 2022

CD BioSciences Introduces In Vitro Kinase Screening and Profiling Services for Drug Development
CD BioSciences has introduced a series of in vitro kinase screening and profiling services for biological research and drug development.
September 01, 2022

CD BioSciences Releases GPCR Peptide Library Service for GPCR Research and Drug Development
CD BioSciences has released new GPCR Peptide Library service for GPCR research and drug development.
August 27, 2022

CD BioSciences Introduces Structural Characterization Services to Advance Kinase/Phosphatase Biology Research
CD BioSciences now introduces a series of structure characterization services for kinase/phosphatase biology research and drug development.
July 23, 2022

CD BioSciences Introduces New GPCR Purification Service for GPCR Research and Drug Development
CD BioSciences introduces new GPCR purification services to support and facilitate GPCR research and drug development.
July 22, 2022

CD BioSciences Announces Solubilization and Stabilization Solution to Simplify GPCR Research
CD BioSciences introduces GPCR solubilization and stabilization services to researchers.
June 14, 2022

CD BioSciences Introduces AMPK Pathways for Research Application
CD BioSciences offers AMPK Pathway to the life science community for researchers focusing on diabetes and metabolism study.
June 11, 2022

CD BioSciences Introduces mTOR Pathway for Metabolism Research
CD BioSciences launches mTOR pathways to the life science community for research applications.
May 26, 2022

CD BioSciences Introduces Comprehensive Solutions for GPCR Expression
CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.
May 25, 2022

CD BioSciences Releases Insulin Signaling Pathway for Researchers
CD BioSciences introduces new insulin signaling pathways to the life science community for research uses.
April 30, 2022

CD BioSciences Introduces GPCR Drug Discovery Services
CD BioSciences introduces a series of GPCR drug discovery services to researchers.
April 14, 2022

CD BioSciences Introduces Genetic Polymorphism Services for GPCRs Study
CD BioSciences introduces a series of Genetic Polymorphism services for the study of GPCR polymorphisms to support customers focused on basic research and drug development process.
March 24, 2022

CD BioSciences Launches Metabolic Signaling Pathways for Research Use
CD BioSciences introduces a comprehensive panel of metabolic signaling pathways to the life science community for research uses.
March 23, 2022

CD BioSciences Introduces Cell Death Solutions for Bio-research
CD BioSciences introduces introduces a comprehensive panel of cell death solutions to the scientific community for biological application.
March 02, 2022

CD BioSciences Introduces Sample Size Calculation Service
CD BioSciences introduces sample size calculation service for drug development in clinical trials.
October 22, 2021

CD BioSciences Announces Adaptive and Bayesian Designs Services
CD BioSciences recently introduces adaptive and bayesian designs service for drug development in clinical trials.
September 17, 2021

CD BioSciences Launches ISS and ISE Study Design Services for Clinical Trials
CD BioSciences introduces ISS and ISE Study Design services for clinical trials.
August 19, 2021

CD BioSciences Introduces Randomization Plan Design Services for Clinical Research
CD BioSciences introduces Randomization Plan Design services for various clinical trials to the scientific and research communities.
July 18, 2021

CD BioSciences Introduces Statistical Analysis Plan Service for Clinical Trials
CD BioSciences now introduces statistical analysis plan services for various clinical trials to the research community.
June 25, 2021

CD BioSciences Releases Meta Analysis Service for Clinical Trials
CD BioSciences introduces meta-analysis services for the research community.
November 10, 2020